You did what you were told. You filled the prescription, waited the weeks it takes to know, and tried to be patient. Maybe you switched to a second medication, then a third. And still the flatness stays. If that is your experience, you are not failing at treatment, and you are not out of options. You may be describing something clinicians have a name for.

What clinicians mean by treatment-resistant

In everyday psychiatric practice, depression is often called treatment-resistant when a person has tried at least two different antidepressant medications, each at an adequate dose for an adequate length of time, without a satisfactory response. The exact definition varies between researchers and guidelines, but the practical meaning is consistent: the standard first moves have not worked, and it is reasonable to consider a different approach.

This matters because the label changes the conversation. It signals that continuing to cycle through similar medications may not be the most useful next step, and that treatments working through different mechanisms deserve a look.

A note on dose and timeAntidepressants generally need several weeks at a therapeutic dose before their full effect can be judged. A medication stopped early, or never raised to an effective dose, has not truly been given a fair trial. This is worth reviewing with your prescriber before concluding a drug did not work.

Why one medication can fail and another can help

Depression is not a single condition with a single cause. The most common antidepressants act mainly on serotonin, and for many people that is enough. For others, it is not. When first-line medications repeatedly fall short, clinicians look at treatments that reach the brain through other pathways entirely, or that skip the bloodstream and work through targeted stimulation.

Two of the better-established options for treatment-resistant depression are worth naming plainly.

Esketamine (Spravato)

Spravato is an FDA-approved nasal spray for treatment-resistant depression, given in a certified clinic under medical supervision. It works on the brain's glutamate system rather than serotonin, which is part of why it can help people who have not responded to conventional antidepressants.

Transcranial magnetic stimulation (TMS)

TMS is an FDA-cleared, non-drug treatment that uses focused magnetic pulses to stimulate the regions of the brain involved in mood regulation. It is done in a series of outpatient sessions, requires no anesthesia, and lets you drive yourself home afterward.

Treatment-resistant does not mean untreatable. It means the map you were handed did not lead where you needed to go, and it is time for a different route.

The Gateway Health Review

What a good next conversation sounds like

If you think you may be in this situation, the most useful thing you can do is bring it directly to a clinician who treats depression regularly. Helpful questions to raise include:

  • Have I had an adequate trial, in both dose and duration, of the medications I have tried?
  • Given that, am I a candidate for treatments that work differently, such as Spravato or TMS?
  • Are there other factors, like thyroid function, sleep, alcohol, or another untreated condition, that could be blunting my response?
  • What would a realistic timeline and plan look like if we change direction now?

Finding this kind of care near St. Louis

Advanced options like esketamine and TMS are delivered at specialized outpatient clinics rather than in a typical primary-care visit, and the St. Louis and St. Charles County area has clinics that focus specifically on treatment-resistant depression. Our guide on how to get help locally walks through how to start, and our piece on paying for care covers insurance and MO HealthNet coverage. The goal is simple: get a real evaluation, and stop waiting for a medication that has already had its fair chance.